Phosphate Research – IMPHOS http://imphos.org/ Fri, 24 Sep 2021 21:00:11 +0000 en-US hourly 1 https://wordpress.org/?v=5.8 https://imphos.org/wp-content/uploads/2021/08/IMPHOS-icon-150x150.jpg Phosphate Research – IMPHOS http://imphos.org/ 32 32 Another class of MS drugs raises concerns over COVID vaccine protection https://imphos.org/another-class-of-ms-drugs-raises-concerns-over-covid-vaccine-protection/ https://imphos.org/another-class-of-ms-drugs-raises-concerns-over-covid-vaccine-protection/#respond Fri, 24 Sep 2021 21:00:11 +0000 https://imphos.org/another-class-of-ms-drugs-raises-concerns-over-covid-vaccine-protection/ Multiple sclerosis (MS) patients treated with cladribine (Mavenclad) or teriflunomide (Aubagio) experienced an appropriate humoral response against SARS-CoV-2 one month after vaccination, but those treated with anti- CD20 or the sphingosine-1-phosphate (S1P) receptor modulators did not, a Swiss study showed. Out of 120 MS patients at the Neurocenter of Southern Switzerland who received the Moderna […]]]>

Multiple sclerosis (MS) patients treated with cladribine (Mavenclad) or teriflunomide (Aubagio) experienced an appropriate humoral response against SARS-CoV-2 one month after vaccination, but those treated with anti- CD20 or the sphingosine-1-phosphate (S1P) receptor modulators did not, a Swiss study showed.

Out of 120 MS patients at the Neurocenter of Southern Switzerland who received the Moderna or Pfizer-BioNTech (Comirnaty) mRNA vaccine, the percentage remaining seronegative 21-35 days after the second dose was 48.2% in a group receiving anti-CD20 therapies, 33.3% in the S1P modulator group, 7.1% in the cladribine group, 0% in the teriflunomide group and 0% in a group that received no MS treatment, reported Claudio Gobbi, MD, from the Neurocenter of Southern Switzerland in Lugano, and co-authors, in a JAMA Neurology research letter.

A total of 58 patients were on anti-CD20, including 32 on ocrelizumab (Ocrevus), 25 on rituximab (Rituxan) and one on ofatumumab (Kesimpta). Nine people were on S1P modulators, including seven on fingolimod (Gilenya) and two on ozanimod (Zeposia). The cohort also included 15 MS patients on cladribine, 24 on teriflunomide and 14 without treatment. Serum samples were taken in the 2 weeks before the first dose of vaccine and on average 26 days after the second dose.

In a short related report, also published in JAMA Neurology, researchers in Israel showed that MS patients on ocrelizumab generated specific T-cell responses to SARS-CoV-2 comparable to healthy controls, but had a weaker antibody response after the Pfizer COVID-19 vaccine.

“Given the potential role of T cells in protecting against serious illness, this is reassuring and will help doctors develop consensus guidelines for treating MS in the era of the COVID-19 pandemic,” said writes Adi Vaknin-Dembinsky, MD, PhD, of Hadassah Medical Center in Jerusalem, and colleagues.

Of the 112 participants in the single-center study, 49 had MS and were treated with ocrelizumab, 23 had MS and were not treated with DMARDs, and 40 were healthy controls.

2-8 weeks after their second vaccine injection, 26 of 29 MS patients (89.7%) treated with ocrelizumab and 15 of 15 healthy controls had SARS-CoV-2 specific T cells at similar levels (mean 15.4 and 14.3 cells, respectively). A lower percentage of positive SARS-CoV-2 antibody response and lower IgG titers were observed in patients treated with ocrelizumab than in healthy controls and untreated patients.

The findings echo those recently seen in other small studies on immune responses in MS patients on anti-CD20 therapy after COVID vaccination. They also reflect data showing weaker COVID antibody responses in MS patients on anti-CD20 treatment who were infected with COVID-19.

An earlier study showed an altered humoral response to COVID-19 vaccination for MS patients on ocrelizumab and S1P receptor modulators. In addition, a preprint paper on medRxiv, not yet peer-reviewed, showed that anti-CD20 drugs and S1P receptor modulators resulted in a significant reduction in spike-specific IgG responses after COVID vaccines.

Ocrelizumab depletes circulating B cells within 2 weeks of treatment, but spares CD20 negative plasma cells, stem cells and pro-B cells, observed Vaknin-Dembinsky and co-authors.

“We found that patients vaccinated 5 months or more after the last dose had a higher likelihood of a positive serologic response,” they wrote. “The individual serological response may depend on a combination of factors.”

Vaccines timed with doses of ocrelizumab – a strategy recommended by the National Multiple Sclerosis Society – may improve antibody responses, noted Vaknin-Dembinsky and colleagues. It is not known to what extent patients who have a negative serologic response but who produce vaccine-specific T cells are protected, they added.

  • Judy George covers neurology and neuroscience news for MedPage Today, writing about brain aging, Alzheimer’s disease, dementia, MS, rare diseases, epilepsy, autism, headaches , stroke, Parkinson’s disease, ALS, concussions, CTE, sleep, pain and more. To follow

Disclosures

The Swiss study was supported by institutional funds from the Neurocenter in southern Switzerland. Researchers reported relationships with Gilead Sciences, MSD, ViiV Healthcare, AbbVie, Pfizer, Almirall, Biogen, Celgene, Merck, Novartis, Roche, Sanofi Genzyme, Teva, Lilly, and Lundbeck.

The Israeli study was partially supported by F. Hoffmann-La Roche, who developed and markets ocrelizumab. The researchers reported relationships with F. Hoffmann-La Roche, Roche, Biogen, Genzyme Sanofi, Merck, Novartis and the Israel Ministry of Health.



Source link

]]>
https://imphos.org/another-class-of-ms-drugs-raises-concerns-over-covid-vaccine-protection/feed/ 0
Long-term CRYSVITA® ▼ (burosumab) treatment reduces disease burden in adults with X-linked hypophosphatemia (XLH), a rare genetic metabolic bone disease https://imphos.org/long-term-crysvita-%e2%96%bc-burosumab-treatment-reduces-disease-burden-in-adults-with-x-linked-hypophosphatemia-xlh-a-rare-genetic-metabolic-bone-disease/ https://imphos.org/long-term-crysvita-%e2%96%bc-burosumab-treatment-reduces-disease-burden-in-adults-with-x-linked-hypophosphatemia-xlh-a-rare-genetic-metabolic-bone-disease/#respond Fri, 24 Sep 2021 08:00:00 +0000 https://imphos.org/long-term-crysvita-%e2%96%bc-burosumab-treatment-reduces-disease-burden-in-adults-with-x-linked-hypophosphatemia-xlh-a-rare-genetic-metabolic-bone-disease/ TOKYO – (COMMERCIAL THREAD) – Kyowa Kirin Co., Ltd. (TSE: 4151, Kyowa Kirin) today announced the release of new data highlighting the lasting benefits of treatment with CRYSVITA® (burosumab) in adults with X-linked hypophosphatemia (XLH), a rare genetic metabolic bone disease. Data shows that adults with XLH experience significant pain, stiffness, fatigue, and impaired physical […]]]>

TOKYO – (COMMERCIAL THREAD) – Kyowa Kirin Co., Ltd. (TSE: 4151, Kyowa Kirin) today announced the release of new data highlighting the lasting benefits of treatment with CRYSVITA® (burosumab) in adults with X-linked hypophosphatemia (XLH), a rare genetic metabolic bone disease. Data shows that adults with XLH experience significant pain, stiffness, fatigue, and impaired physical and ambulatory functions. CRYSVITA treatment was associated with significant improvement from baseline after 96 weeks.1

The data are from a randomized, double-blind, placebo-controlled phase 3 study with an open-label extension to evaluate the efficacy and safety of CRYSVITA in adults with XLH.2 The study met its primary endpoint, showing a statistically significant effect in increasing serum phosphorus concentrations at 24 weeks, compared to placebo.3 After 24 weeks, all patients switched to CRYSVITA treatment and data were collected on metabolic and biochemical markers, patient reported outcomes (PRO) and mobility measures up to 96 weeks. This new publication focuses on the results of PRO analysis and mobility scores.1

At week 96, the study showed statistically significant improvements in PROs, including Western Ontario and McMaster University Osteoarthritis Index (WOMAC), Brief Pain Inventory-Short Form (BPI-SF), and Brief Fatigue Inventory (BFI), against baseline.1 Statistically significant improvements in ambulatory function, as measured by the 6-minute walk test (6MWT), were also seen at 96 weeks from baseline.1 Previously published data at 48 weeks also showed improvements in some PROs, including stiffness and pain, as well as healing of fractures.3

Lead author Pr Karine Briot, Hôpital Cochin, Paris, France said: “The study highlights the many physical challenges faced by adult patients with XLH, including pain, stiffness, fatigue and difficulty. to walk or to function physically. Burosumab treatment has already been shown to improve phosphate homeostasis in adult patients with XLH compared to placebo. This new analysis suggests that, despite the long-term complications and physical impairment associated with XLH in adults, treatment with burosumab may also improve the physical function and quality of life of adults with XLH in the longer term.

Tomohiro Sudo, Executive Officer, Head of Global Product Strategy Department at Kyowa Kirin, said: “Kyowa Kirin is committed to improving the lives of people with XLH and their families. One of our areas of interest is to generate new data that improves our understanding of how best to manage and treat XLH. This important new data highlights the many physical challenges people living with XLH face every day, how their needs could be better met, and how Kyowa Kirin achieves her goal of making people smile.

The data was released today in the BMJ newspaper RMD Open, rheumatic and musculoskeletal diseases.1 CRYSVITA is approved in Europe for the treatment of XLH in children and adolescents aged 1 to 17 years with radiographic evidence of bone disease, and in adults.4

This medicine is subject to additional monitoring.

About X-linked hypophosphatemia

X-linked hypophosphatemia (XLH) is a rare genetic disorder that causes abnormalities in bones, muscles, and joints.5.6 XLH is not life threatening, but its burden is permanent and progressive, and it can reduce a person’s quality of life.7

People with XLH have a genetic defect on the X chromosome, which causes excessive loss of phosphate through the urine and poor absorption from the intestine due to the excess of a hormone known as blood factor. growth of fibroblasts-23 (FGF23), resulting in a chronic low level of phosphate in the blood.4.8 Phosphate is a key mineral needed to maintain the body’s energy levels, muscle function, and the formation of healthy bones and teeth.9.10 While there is no cure for XLH, therapies aimed at helping restore and maintain phosphate to normal levels in the body may help improve the progression of symptoms of the disease.2

XLH is the most common form of inherited rickets.11 It can sometimes appear in individuals without a family history of the disease, but is usually passed on from a parent with the defective gene.12

About CRYSVITA® (burosumab)

CRYSVITA (burosumab) was created and developed by Kyowa Kirin and is a fully human recombinant IgG1 monoclonal antibody directed against the fibroblast growth factor, phosphaturic hormone 23 (FGF23). FGF23 is a hormone that reduces serum phosphate levels by regulating phosphate excretion and active production of vitamin D by the kidneys. The wasted phosphate and the resulting hypophosphatemia in X-linked hypophosphatemia (XLH) are caused by an excess of FGF23. CRYSVITA is designed to bind to, and thereby inhibit, the biological activity of FGF23. By blocking excess FGF23 in patients, CRYSVITA is intended to increase the reabsorption of phosphate by the kidney and increase the production of active vitamin D, which improves the intestinal absorption of phosphate and calcium.

CRYSVITA has been available for clinical use since 2018. The first approval came from the European Commission, which granted conditional marketing authorization for CRYSVITA for the treatment of XLH with radiographic evidence of bone disease in pediatric patients. ‘one year old and older and growing teenagers skeletons. In 2020, this authorization was then extended to older adolescents and adults.2

CRYSVITA is approved by the United States Food and Drug Administration (FDA) for patients with XLH aged 6 months and older and by Health Canada for patients with XLH aged one year and older.13.14

In 2019, CRYSVITA received approval from the Japanese Ministry of Health, Labor and Welfare for the treatment of hypophosphatemic rickets and osteomalacia related to FGF23. In 2020, CRYSVITA was reimbursed by the National Health Insurance (NHI) in Japan as a self-injection presentation for the treatment of FGF23-related hypophosphatemic rickets and osteomalacia.

In January 2020, Swissmedic approved CRYSVITA for the treatment of adults, adolescents and children (aged one year and over) with XLH.15

In June 2020, the United States Food and Drug Administration (FDA) approved CRYSVITA for patients two years of age and older with tumor-induced osteomalacia (TIO), a rare disease characterized by the development of tumors that weaken and soften bones.16

Kyowa Kirin and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE: Ultragenyx) have collaborated in the development and commercialization of CRYSVITA on a global scale, based on the collaboration and license agreement between Kyowa Kirin and Ultragenyx.

About Kyowa Kirin

Kyowa Kirin strives to create and deliver new medicines with life changing value. As a Japan-based global specialty pharmaceutical company with a heritage of over 70 years, the company applies cutting-edge science, including expertise in antibody research and engineering, to meet the needs of patients and the community. company in multiple therapeutic areas, including nephrology, oncology, Immunology / Allergy and Neurology. In our four regions – Japan, Asia Pacific, North America and EMEA / International – we are focused on our goal, making people smile, and are united by our common values ​​of commitment to life, teamwork. / Wa, innovation and integrity. You can find out more about Kyowa Kirin’s activity at: https://www.kyowakirin.com/

Kyowa Kirin International

http://www.international.kyowa-kirin.com / www.kyowakirin.com

Galabank Business Park

Galashiels, TD1 1QH

UK

The references


1 Briot K, Portale AA, Brandi ML, et al. RMD open 2021;7:e001714. doi: 10.1136 / rmdopen-2021-001714.

2 Insogna KL, Rauch F, Kamenický P, et al. Burosumab improved histomorphometric measures of osteomalacia in adults with X-linked hypophosphatemia: an international phase 3 single-arm trial. J Bone Miner Res. 2019; 34: 2183-2191.

3 Portale AA, Carpenter TO, Brandi ML, et al. Calcif Tissue Int 2019; 105: 271–84.

4 European Medicines Agency. Product information CRYSVITA EPAR. Summary of product characteristics. Available from: Crysvita, INN-burosumab; (europa.eu). Last update: June 2021. Last viewed: July 2021.

5 Linglart A, Biosse-Duplan M, Briot K, et al. Therapeutic management of hypophosphatemic rickets from infancy to adulthood. Endocr Connect. 2014; 3: R13-30.

6 Haffner D, Emma F, Eastwood DM et al. Consensus statement. Evidence-based guideline. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphatemia. Nat Rev Nephrol. 2019; 15; 435-455.

7 Skrinar A, Dvorak-Ewell M, Evins A, et al. The lifelong impact of X-linked hypophosphatemia: findings from a disease burden investigation. J Endocr Soc. 2019; 3: 1321-1334.

8 Beck-Nielsen SS, Mughal Z, Haffner D, et al. FGF23 and its role in X-linked hypophosphatemia-related morbidity. Orphanet J Rare Dis. 2019; 14: 58.

9 Pesta D, Tsirigotis DN, Befroy DE, et al. Hypophosphatemia promotes lower rates of muscle ATP synthesis. The FAESB review. 2016; 39: 3378-3387.

ten Unnanuntana A, Rebolledo BJ, Khair MM et al. Diseases affecting bone quality: beyond osteoporosis. Clin Orthop Relat Res. 2011; 469: 2194-2206.

11 Carpenter TO, Imel EA, Holm IA, et al. A clinician’s guide to X-linked hypophosphatemia. J Bone Miner Res. 2011; 26: 1381-8.

12 National Center for the Advancement of Translational Sciences. X-linked hypophosphatemia. Available at: https://rarediseases.info.nih.gov/diseases/12943/x-linked-hypophosphatemia. Last update: February 2018. Last consulted: July 2021.

13 Health Canada. Summary of Regulatory Decision – CRYSVITA. Available at: https://hpr-rps.hres.ca/reg-content/regulatory-decision-summary-detail.php?linkID=RDS00463. Last update: April 2020. Last consulted: April 2021.

14 Available at: https://www.kyowakirin.com/media_center/news_releases/2019/e20190930_01.html. Last consulted: July 2021

15 Swissmedic. Crysvita, injektionslösung (burosumabum). Available at: https://www.swissmedic.ch/swissmedic/en/home/humanarzneimittel/authorisations/new-medicines/vrysvita-injektionsloesung_burosumabum.html. Last update: January 2020. Last consulted: July 2021.

16 FDA. Available at: FDA Approves First Treatment for Rare Disease That Causes Low Blood Phosphate Levels and Softened Bones | FDA. Last consulted: July 2021

KKI / INT / BUR / 1174


Source link

]]>
https://imphos.org/long-term-crysvita-%e2%96%bc-burosumab-treatment-reduces-disease-burden-in-adults-with-x-linked-hypophosphatemia-xlh-a-rare-genetic-metabolic-bone-disease/feed/ 0
Haifa Group, Master Plant-Prod, Foodchem International Corporatio – Le current Manomet https://imphos.org/haifa-group-master-plant-prod-foodchem-international-corporatio-le-current-manomet/ https://imphos.org/haifa-group-master-plant-prod-foodchem-international-corporatio-le-current-manomet/#respond Thu, 23 Sep 2021 16:37:43 +0000 https://imphos.org/haifa-group-master-plant-prod-foodchem-international-corporatio-le-current-manomet/ Global Monopotassium Phosphate Market Report 2021 brings a systematic perspective of market performance worldwide and in addition to the regional situation. In a nifty arrangement of detailed sections, Monopotassium Phosphate contemplates that make sense of the different perspectives relating to the world market. To begin with, the market definition, applications, arrangement and structure of the […]]]>

Global Monopotassium Phosphate Market Report 2021 brings a systematic perspective of market performance worldwide and in addition to the regional situation. In a nifty arrangement of detailed sections, Monopotassium Phosphate contemplates that make sense of the different perspectives relating to the world market. To begin with, the market definition, applications, arrangement and structure of the esteem chain of the monopotassium phosphate industry are incorporated into the answer, to target a gathering of people on the restriction of market elements of the Monopotassium Phosphate including Motors, Limitations, Openings, Models, Applications, Topographic / Local Monopotassium Phosphate Markets and Aggressive Scene.

REMARK: Consumer behavior has changed across all sectors of society amid the COVID-19 pandemic. For their part, industries will have to restructure their strategies in order to adapt to changing market demands. This report offers you an analysis of the impact of COVID-19 on the Monopotassium Phosphate market and will help you strategize for your business according to the new industry standards.

Request a PDF report at: https://courant.biz/request-sample/?id=64973

The Global Monopotassium Phosphate Market is an in-depth study of new advancements and expert analysis to help you plan for the next year. The study discusses new industry data and advanced future trends, decision makers of Monopotassium Phosphate, forecast, analysis and discussion of business facts, Monopotassium Phosphate market size, from the market share assessment which gives a good understanding of the overall Monopotassium Phosphate industry.

The report enables consumers to identify Monopotassium Phosphate market by applications, types, manufacturers and forecast till 2026. It gives a brief introduction of Monopotassium Phosphate business overview, revenue division, research results and conclusion.

Rivalry of Monopotassium Phosphate market by major manufacturers / players, with Monopotassium Phosphate trading volume, value (USD / Unit), revenue (Mn / Bn USD) and market size for each producer / player;

The important players are:

  • Haifa Group
  • Master Plant-Prod
  • Foodchem International Corporation
  • Green Kosumosu Fertilizer Co.
  • Sichuan Blue Sword Chemical
  • Shifang Chemical Talent
  • IFT Jiangsu Mupro
  • Food Ingredients of Lianyungang Dongtai
  • Azot-Trans

Based on the type, the Monopotassium Phosphate Market report shows the development rate of each type, covers:

  • Industrial level
  • Fertilizer Category
  • Food grade
  • Pharmaceutical grade

End Customers / Applications, The Monopotassium Phosphate Market report focuses on the status and viewpoint of the top applications / end customers, the development rate for each application, this can be isolated in:

  • Food industry
  • Production of compound fertilizers
  • Metaphosphate production
  • Medical domain
  • Others

Fragment of the monopotassium phosphate market by zones, the territorial examination covers

  • United States
  • Europe
  • Japan
  • China
  • India
  • South East Asia

For more information Find out here:https://courant.biz/report/world-monopotassium-phosphate-market-2/64973/

Our report offers:

  1. Monopotassium Phosphate Market Review
  2. Review of Monopotassium Phosphate by Type
  3. Survey by application
  4. Examination by district
  5. By the players
  6. Player Analysis of Monopotassium Phosphate Industry
  7. Monopotassium Phosphate Forecast Estimate by Type, Applications and Major Regions

BROWSE THE FULL REPORT AND TABLE OF CONTENTS:https://courant.biz/report/world-monopotassium-phosphate-market-2/64973/

Highlights of the Global Monopotassium Phosphate Market Report:

  • The international Monopotassium Phosphate market report covers a comprehensive assessment of the opportunities and challenges in the Monopotassium Phosphate market. An in-depth assessment of the Monopotassium Phosphate business plans of top players combined with the latest inventions and crucial events in the Monopotassium Phosphate market is discussed in the research.
  • The primary target audience for this Monopotassium Phosphate report includes Monopotassium Phosphate suppliers and service providers, educational institutions, research institutes, associations, consultancies, and manufacturing companies related to Monopotassium Phosphate. The international Monopotassium Phosphate research report provides exact knowledge about current and future Monopotassium Phosphate market movements, organizational requirements, and industry trends.
  • The consumer will find a deeper understanding of the drivers, constraints and crucial micro-niches specific to the monopotassium phosphate industry. Moreover, the Monopotassium Phosphate market report draws a critical analysis of this expansion map of the Monopotassium Phosphate market and market trends affecting the Monopotassium Phosphate market for the coming years.

Customization of the report:
This report can be customized to meet customer requirements. Please connect with our sales team (sales@courant.biz), who will make sure you get a report that’s right for you.


Source link

]]>
https://imphos.org/haifa-group-master-plant-prod-foodchem-international-corporatio-le-current-manomet/feed/ 0
Grainy vegetables can help corn crops get the missing nutrients … https://imphos.org/grainy-vegetables-can-help-corn-crops-get-the-missing-nutrients/ https://imphos.org/grainy-vegetables-can-help-corn-crops-get-the-missing-nutrients/#respond Wed, 22 Sep 2021 14:09:29 +0000 https://imphos.org/grainy-vegetables-can-help-corn-crops-get-the-missing-nutrients/ One of the most read articles on MyScienceWork this month was about intercropping. This method of cultivation helps to acidify the soils of arid regions, thus facilitating the dissolution of phosphorus. When it comes to agriculture, most minds imagine fields of wheat, corn or lavender as far as the eye can see. Monoculture is currently […]]]>

One of the most read articles on MyScienceWork this month was about intercropping. This method of cultivation helps to acidify the soils of arid regions, thus facilitating the dissolution of phosphorus.

When it comes to agriculture, most minds imagine fields of wheat, corn or lavender as far as the eye can see. Monoculture is currently the most visible form of agriculture in all landscapes. However, this is by no means the only form of agriculture that exists. In some arid regions, where nutrients are not present in sufficient quantities in the soil, new cultivation methods could alleviate this problem.

Authors Sareban Hadi, Madani Ahad, and Vazin Farshid from the Agronomy Department at Azad Islamic University in Gonabad, Iran, this year published an article on intercropping of pulses. Published in the Egyptian agricultural research journal, the article “Encouraging Farmers to Adopt Sustainable Water and nutrient Management in arid agroecosystems: Problems, Solutions and Future Studies” offers solutions to nitrogen and phosphorus deficiency in arid soils. using intercropping methods.

In acidic soils, phosphorus and nitrogen are essential elements present in too small quantities. Intercropping involves planting other things at the same time as the main crop, in this case pulses. These legumes, used with sunflower, corn, cotton or other crops, could allow the introduction of missing nutrients. This is because legumes increase H ions in the soil, which has the effect of acidifying the soil. And a more acidic soil helps dissolve phosphorus better. This is true in today’s wheat / legume intercrops, where phosphorus uptake is higher than in monoculture. Additionally, pulses play other beneficial roles by increasing soil organic matter, nutrient availability, and water retention.

However, adding a component to the main crop is a challenge, as these new components must not “steal” water and nutrients from other plants. For water, the latter is most often deep, so field crops have easy access to it, and the short roots of grain legumes cannot rob them of this resource; but the essential nutrients (nitrogen and phosphorus) are found in homogeneous amounts in the soil. If they are scarce and legumes take over, then the yield is lower for farmers. The solution to this problem is to increase the number of nutrients in the soil, for example with bacteria which solubilize phosphate.

In conclusion, the insertion of pulses in cotton, corn or other crops in arid areas increases the amount of H ions in the soil. These ions acidify the soil, and a more acidic soil dissolves phosphorus better. However, nitrogen fixation by pulses is not sufficient and the addition of nitrogen fertilizer is necessary.

Sareban, Hadi, Ahad Madani and Farshid Vazin. “Encouraging farmers to adopt sustainable water and nutrient management in arid agroecosystems: problems, solutions and future studies.” Egyptian Journal of Agricultural Research 99.2 (2021): 136-141.


Source link

]]>
https://imphos.org/grainy-vegetables-can-help-corn-crops-get-the-missing-nutrients/feed/ 0
Sodium Dihydrogen Phosphate Market Continues to Perform Well with Excellent CAGR (Compound Annual Growth Rate) – Stillwater Current https://imphos.org/sodium-dihydrogen-phosphate-market-continues-to-perform-well-with-excellent-cagr-compound-annual-growth-rate-stillwater-current/ https://imphos.org/sodium-dihydrogen-phosphate-market-continues-to-perform-well-with-excellent-cagr-compound-annual-growth-rate-stillwater-current/#respond Wed, 22 Sep 2021 06:13:13 +0000 https://imphos.org/sodium-dihydrogen-phosphate-market-continues-to-perform-well-with-excellent-cagr-compound-annual-growth-rate-stillwater-current/ A comprehensive professional report providing relevant market research data for new market entrants or established players is the Sodium Dihydrogen Phosphate Market Research Report 2021. The study includes important data that helps managers, CEOs, business analysts , business experts and other key people to get ready-to-access and self-analyzed research, along with charts and tables that […]]]>

A comprehensive professional report providing relevant market research data for new market entrants or established players is the Sodium Dihydrogen Phosphate Market Research Report 2021. The study includes important data that helps managers, CEOs, business analysts , business experts and other key people to get ready-to-access and self-analyzed research, along with charts and tables that help them understand market trends, drivers and challenges. The report combines data integration and analytical ability with relevant findings and predicts strong future growth across all geographic and product segments of the Sodium Dihydrogen Phosphate market.

In addition, the marketing trends and development channels of Sodium Dihydrogen Phosphate industry are analyzed. Industry analysis was also performed to assess the impact of different factors and to understand the overall attractiveness of the industry. A historical analysis of Sodium Dihydrogen Phosphate markets over six years (2012 to 2021) is also provided.

Sample copy of request report @ https://www.marketresearchstore.com/sample/sodium-dihydrogen-phosphate-market-809493

Monosodium Phosphate Market Overview: Impact of Coronavirus on Sodium Dihydrogen Phosphate Market Share, Trends, Demand and Supply, Historical Research, Analysis and Forecast 2026

The report begins with a market outline and reviews the growth prospects of the Sodium Dihydrogen Phosphate market. A detailed analysis of the Monosodium Phosphate market segmentation is available in the report. The analysis also encompasses upstream raw materials, equipment, downstream customer surveys, marketing channels, industry trends and proposals. Additionally, the report contains business overview, revenue share, and SWOT analysis of the major players in the Sodium Dihydrogen Phosphate market.

Geographically, this report is split into several key areas including North America, Europe, China, Japan, Southeast Asia, India and its share (percentage) and CAGR for the period forecast 2019-2024. The region’s production, consumption, revenue (Million US $) and market share and growth rate will cover Sodium Dihydrogen Phosphate ## from 2012 to 2023 (projection).

Major Manufacturers Analysis of Monosodium Phosphate Market: Aditya Birla Chemicals, Prayon, Lianyungang Yunbo Chemical, Suqian Modern Chemical, Guizhou Zerophos Chmeical, GF Fine Phosphate Company, Guizhou Ferti Phosphate, Shifang Tianrui Chemical, Guizhou Qianlin Phosphates Industry, Mitsui Chemicals

This report also provides product specifications, production processes, product cost structures, etc. Regions, technology and applications separate production. Other significant aspects which have been meticulously studied in the Sodium Dihydrogen Phosphate market report are demand and supply dynamics, import and export scenario, industrial processes, and cost structures, and the main R&D initiatives. Ultimately, the report includes a SWOT analysis of the Sodium Dihydrogen Phosphate New Project, Investment Feasibility Analysis, Return on Investment Analysis, and Development Trend Analysis.

Browse the full report with TOC @ https://www.marketresearchstore.com/market-insights/sodium-dihydrogen-phosphate-market-809493

The questions are answered in the Sodium Dihydrogen Phosphate Market Report:

  1. Market trends (drivers, constraints, opportunities, threats, challenges, investment opportunities and recommendations)
  2. What are the markets in which companies should be present with detailed strategies, financing and recent developments?
  3. What limitations will jeopardize the growth rate?
  4. What are the predicted growth rates for the Sodium Dihydrogen Phosphate market as a whole and for each segment within it?
  5. How big is the market opportunity?
  6. What are the types and applications of manufacturers?
  7. How to share the market changes in their values ​​by the different manufacturing brands?

All of these questions are answered through advanced techniques and instruments and a wide range of qualitative research.

The report also assesses the cost of manufacturing the products and the price structure of the market. The report also includes other parameters that are crucial to determine market trends, such as consumption and supply figures, cost of production, gross profit margins, and selling prices of products and services. This report is about a combination of basic information based on important data such as the key factor responsible for fluctuating demand for products and services in the global market.

Key Product Types:

Food grade, chemical grade

Key product applications:

Fertilizers, food applications, chemical industry, pharmaceuticals.

Market size segmentation by region and country:

  • United States, Canada: North America
  • Europe: Germany, France, United Kingdom, Italy, Spain (Russia, Netherlands, Switzerland, Poland, Sweden, Belgium, Norway, Austria, Ireland, Denmark, etc.)
  • Asia-Pacific: Chinese, Japanese, Indian, Southeast Asian (Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, etc.) (Australia, New Zealand, Bangladesh, Kazakhstan, Uzbekistan, etc.)
  • Rest of Latin America: Brazil, Mexico (Chile, Argentina, Colombia, Peru, etc.)
  • Middle East and Africa (GCC countries) South Africa, Middle East rest of Africa (Saudi Arabia, Kuwait, Oman, Qatar, Bahrain and United Africans) (Iran, Turkey, Israel, Egypt, Nigeria, Algeria , Morocco, Kenya, Tanzania, Ghana, Angola, etc.)

To conclude, this is an in-depth research report on the Global Sodium Dihydrogen Phosphate Industry. We thank you here for the support and assistance given during the investigation and interviews of the research team by the technical experts and marketing engineers of the sodium dihydrogen phosphate industry chain #

Read / buy our top selling trends and report requests:

1. The market size for VoIP services is growing rapidly even under the influence of COVID-19

2. Professional Flexible Packaging Adhesives Technology market analyst predicts market scenario based on current market state

Call for a personalization purchase report: https://www.marketresearchstore.com/inquiry/sodium-dihydrogen-phosphate-market-809493


Source link

]]>
https://imphos.org/sodium-dihydrogen-phosphate-market-continues-to-perform-well-with-excellent-cagr-compound-annual-growth-rate-stillwater-current/feed/ 0
Vitamin D and bladder health have a key link https://imphos.org/vitamin-d-and-bladder-health-have-a-key-link/ https://imphos.org/vitamin-d-and-bladder-health-have-a-key-link/#respond Tue, 21 Sep 2021 16:19:06 +0000 https://imphos.org/vitamin-d-and-bladder-health-have-a-key-link/ WWhile having a healthy heart and brain are priority goals for many, bladder health is something that people don’t tend to think about until there is a problem. But it is in fact vital. Anyone who suffers from an overactive bladder, inconvenience, pelvic floor disorder, or repeated urinary tract infections will tell you that when […]]]>

WWhile having a healthy heart and brain are priority goals for many, bladder health is something that people don’t tend to think about until there is a problem. But it is in fact vital. Anyone who suffers from an overactive bladder, inconvenience, pelvic floor disorder, or repeated urinary tract infections will tell you that when something goes wrong with your bladder it can really take over your life.

That’s why, whether you currently have a health issue with your bladder or want to think about it proactively, it’s important to know which nutrients can help you. There’s one bladder health nutrient that new research shows is crucial and that most people don’t get enough of: vitamin D.

According to an article highlighting new research published in International Journal of Urogynecology, a lack of vitamin D is linked to an overactive bladder, urinary incontinence, pelvic floor disorders and lower urinary tract symptoms. Researchers conducted a review of previous studies – all of which took place in August 2020 – and analyzed the data collectively, finding a clear link between vitamin D and bladder health. Curious as to why there is a link? Read on to find out more, straight from a urologist.

Bladder Health Nutrients

While recently published research shows a clear link between vitamin D and bladder health, urologist and female pelvic medicine specialist Michael Ingber, MD, says the reasoning is still not fully understood. But he says one of the reasons it’s beneficial is because it helps other nutrients related to bladder health be better absorbed into the body.

“Vitamin D is a fat soluble vitamin, which plays a role in the intestinal absorption of several different nutrients in the body. Calcium, magnesium, phosphate are all absorbed by vitamin D, and these elements also play a role. in kidneys. and bladder health, ”he explains.“ Recently, studies have evaluated vitamin D deficiency and its effect on urinary incontinence. It seems that a vitamin D deficiency makes a person more prone to urinary incontinence. “

The reason calcium is important for bladder health is that it helps muscle contraction, including the detrusor muscle. This muscle is found in the walls of the bladder and it stays relaxed to allow the bladder to store urine, contracting when you urinate to release it. Magnesium and phosphate also play a role in muscle and nerve function. Calcium is also linked to the prevention of kidney stones. As Dr. Ingber explains, vitamin D helps in the absorption of these nutrients, which could be one of the main reasons it’s so important for bladder health.

New International Journal of Urogynecology The article also points to vitamin D receptors found in skeletal and smooth muscle cells, including the detrusor muscle. Besides helping with nutrient absorption, this points to another key reason the nutrient is so important for bladder health.

How To Make Sure You’re Getting Enough Nutrients That Support A Healthy Bladder

Unfortunately, nearly half of the American population does not get enough vitamin D. The bladder isn’t the only reason it’s important to get enough. Not getting enough vitamin D is linked to a higher risk of certain types of cancer, muscle weakness, and digestive distress. “There are several ways to increase vitamin D levels, the first being diet,” says Dr. Ingber. “Foods rich in vitamin D include fatty fish like salmon, cod liver oil, canned tuna.”

If you’re a vegan and don’t eat fish, he says you may want to consider a vitamin D supplement. get half of it, that’s probably enough for most people, ”he says. Dr Ingber says the sun is also a good source of vitamin D, although it is always important to wear sunscreen to soak up it. Just 15 minutes of direct sunlight a day can help meet vitamin D needs.

Remember how important calcium, magnesium, and phosphate are for bladder health? This trio of nutrients can also be found in foods. Dairy products, leafy greens, and broccoli are all high in calcium; spinach, almonds, peanut butter, and dark chocolate are all good sources of magnesium; and dairy products, bread, fish and olive oil all contain phosphate. In addition to these nutrients, according to Dr. Ingber, if you regularly suffer from UTIs, it is also important to drink plenty of water and you may also want to consider a cranberry concentrate tablet.

Here’s the problem: Since vitamin D is linked to many health benefits and ensures that other important nutrients are well absorbed by the body, enough intake supports your whole body, not just your bladder. Take this as a sign to step away from the computer and take a short walk in the sun. Hey, doctor’s orders.

Oh hi! You look like someone who loves free workouts, discounts for top wellness brands, and exclusive Well + Good content. Sign up for Well +, our online community of wellness insiders, and unlock your rewards instantly.


Source link

]]>
https://imphos.org/vitamin-d-and-bladder-health-have-a-key-link/feed/ 0
Global Sphingosine 1-Phosphate Receptor 1 Market Statistics 2021-2028 Novartis AG, Bristol-Myers Squibb Company – The Manomet Current https://imphos.org/global-sphingosine-1-phosphate-receptor-1-market-statistics-2021-2028-novartis-ag-bristol-myers-squibb-company-the-manomet-current/ https://imphos.org/global-sphingosine-1-phosphate-receptor-1-market-statistics-2021-2028-novartis-ag-bristol-myers-squibb-company-the-manomet-current/#respond Tue, 21 Sep 2021 04:17:17 +0000 https://imphos.org/global-sphingosine-1-phosphate-receptor-1-market-statistics-2021-2028-novartis-ag-bristol-myers-squibb-company-the-manomet-current/ Sphingosine 1-Phosphate Receptor 1 Market Highest Growing Companies 2021-28 In the global Sphingosine 1-Phosphate Receptor 1 market, we have utilized advanced and detailed formative research which is useful for both existing and new customers to analyze their business-driven analysis which is also relevant and suitable for their vision. The research report on Global Sphingosine 1-Phosphate […]]]>

Sphingosine 1-Phosphate Receptor 1 Market Highest Growing Companies 2021-28

In the global Sphingosine 1-Phosphate Receptor 1 market, we have utilized advanced and detailed formative research which is useful for both existing and new customers to analyze their business-driven analysis which is also relevant and suitable for their vision. The research report on Global Sphingosine 1-Phosphate Receptor 1 Market can be briefly customized to explain the analysis of price trends of particular products to understand special regions around the world and their performance in the international market. The report also analyzes leading competitors on the basis of technology-driven analysis to demonstrate Sphingosine 1-Phosphate Receptor 1 market portfolio strategies. In addition, our team of researchers can also offer you much-needed information in a Easily understandable format which can enable you to grasp the possible opportunities present in the global Sphingosine 1-Phosphate Receptor 1 market.

Get Free Sample PDF Report of Sphingosine 1-Phosphate Receptor 1 Market Report: https://calibreresearch.com/report/global-sphingosine-1phosphate-receptor-1-market-144293#request-sample

The new study on the Sphingosine 1-Phosphate Receptor 1 market offers an in-depth analysis of the global Sphingosine 1-Phosphate Receptor 1 market report that briefly explains the major applications used, growth analysis, trends and forecast of the Sphingosine 1-Phosphate Receptor 1 industry to 2027. The global Sphingosine 1-Phosphate Receptor 1 market report is expected to exhibit outstanding growth in terms of value and volume over the forecast period of 2021 to 2027. Further , it provides detailed information, revenue assessment, and other crucial data regarding Sphingosine 1 -Phosphate Receptor 1 market along with various trends, restraints, threats, opportunities, as well as challenges faced by players. industry essentials of the sphingosine 1-phosphate receptor 1.
The recent report gives insightful and descriptive information on the many major players working in the global Sphingosine 1-Phosphate Receptor 1 market, their financial status, technological innovations, major development and supply chain trends, strategies to come, acquisitions and mergers and the industrial footprint. cited in this report. The global Sphingosine 1-Phosphate Receptor 1 market report has been categorized on the basis of application, regions, players, and product types.

Impact of COVID-19 on the Global Sphingosine 1-Phosphate 1 Receptor Industry:

In this study report, we have included a detailed and comprehensive analysis of the impact of the COVID-19 pandemic on all economies around the world. Our researchers have demonstrated systematic investigations into this ongoing health crisis which has hampered all industries and is also having a massive impact on the global Sphingosine 1-Phosphate Receptor market 1. New research paper on Sphingosine 1- market Phosphate Receptor 1 has also represented potential growth prospects related to the global Sphingosine 1-Phosphate Receptor 1 industry which has been developed during the COVID-19 outbreak.

If you have any questions / inquiries about Sphingosine 1-Phosphate Receptor 1 Industry Report: https://calibreresearch.com/report/global-sphingosine-1phosphate-receptor-1-market-144293#inquiry-for-buying

In addition to this, the research report on the global Sphingosine 1-Phosphate Receptor 1 market presents a wide range of business-induced facts and figures that have also been affected by the COVID-19 outbreak. In addition, our group of researchers conducted an in-depth assessment of the desirable business growth that will be observed during the post-pandemic phase of COVID-19. Most believe that Caliber Research offering 20% ​​discount of Global Sphingosine 1-Phosphate Receptor 1 Market Report.

Major manufacturers covered in the report are:

Novartis AG
Bristol-Myers Squibb Company

Global Sphingosine 1-Phosphate 1 Receptor Market Segmentation By Product Types:

Fingolimod
Siponimod
Ozanimod
Other

Global Sphingosine 1-Phosphate 1 Receptor Market Segmentation By Application:

Hospital
Clinical
Other

Sphingosine 1-phosphate receptor 1

Detailed Sphingosine 1-Phosphate 1 Receptor market research report with table of contents for better understanding (size, trend, demand, company profile, overview, industry status, competitors): https://calibreresearch.com/report/global-sphingosine-1phosphate-receptor-1-market-144293#table-of-content

Analysis of regions and primitive units covered in the Sphingosine 1-Phosphate Receptor 1 report with table of contents 2017-2028

1. Sphingosine 1-Phosphate Receptor Market Overview
2. Global Sphingosine 1-Phosphate 1 Receptor Market Competition by Players / Suppliers, Type and Application
3.US Sphingosine 1-Phosphate Receptor 1 Market (Volume, Value and Sale Price)
4.China Sphingosine 1-Phosphate Receptor 1 Market (Volume, Value and Sale Price)
5.European Sphingosine 1-Phosphate 1 Receptor Market (Volume, Value & Sale Price)
6. Japan Sphingosine 1-Phosphate Receptor 1 Market (Volume, Value and Sale Price)
7. Southeast Asia Sphingosine 1-Phosphate 1-Phosphate Market (Volume, Value and Sale Price)
8. India Sphingosine 1-Phosphate 1 Receptor Market (Volume, Value & Sale Price)
9. Global Sphingosine 1-Phosphate Receptor 1 Market Suppliers Actors / Profiles and Sales Data
10. Manufacturing Cost Analysis of Sphingosine 1-Phosphate Receptor Market 1
11. Industry chain, sourcing strategy and downstream buyers
12. Analysis of the marketing strategy, distributors / traders
13. Analysis of market effect factors
14. Global Sphingosine 1-Phosphate Receptor 1 Market Forecast (2018-2023)
15. Research results and conclusion
16. Sphingosine 1-Phosphate Receptor 1 Annex

Get a full report for better understanding : https://calibreresearch.com/report/global-sphingosine-1phosphate-receptor-1-market-144293

Competitive Landscape Analysis of Sphingosine 1-Phosphate Receptor 1 Market:

In this section, we have explained an in-depth analysis of the competitive landscape of the global Sphingosine 1-Phosphate Receptor 1 Market by considering a leading approach from major competitors. The details involved are a brief overview of the company, company taxes, revenue generated, industry potential, massive investments in research and development, new industry initiatives, capabilities production potential, the strengths and weaknesses of the company, product launches, etc.

Key Benefits of Global Sphingosine 1-Phosphate Receptor Market 1:

• The research offers an in-depth analysis of the Sphingosine 1-Phosphate 1 Receptor market along with current trends and futuristic estimates to make the impending investment strategies.
• It delivers both quantitative and qualitative analysis from 2021 to 2027 in order to allow industry players to capitalize on existing industrial opportunities.
• The report has provided proprietary analysis of the Sphingosine 1-Phosphate Receptor 1 market which helps in understanding various trends and great opportunities.
• A geographic assessment is offered to assess the key opportunities of these topologies.
• Important players are profiled and their strategies are broadly analyzed, which incorporates the competitive outlook of the Sphingosine 1-Phosphate Receptor 1 market.

Contact us

CALIBER Search
E-mail : sales@calibreresearch.com
Website : https://calibreresearch.com/
Address : 3626 North Hall Street (Two Oak Lawn), Suite 610, Dallas, TX 75219 USA.


Source link

]]>
https://imphos.org/global-sphingosine-1-phosphate-receptor-1-market-statistics-2021-2028-novartis-ag-bristol-myers-squibb-company-the-manomet-current/feed/ 0
Global Industrial Water Testing Kits Market 2021 Industry Scope with Outlook, Business Strategies, Major Key Players and Forecast 2027 https://imphos.org/global-industrial-water-testing-kits-market-2021-industry-scope-with-outlook-business-strategies-major-key-players-and-forecast-2027/ https://imphos.org/global-industrial-water-testing-kits-market-2021-industry-scope-with-outlook-business-strategies-major-key-players-and-forecast-2027/#respond Mon, 20 Sep 2021 17:42:21 +0000 https://imphos.org/global-industrial-water-testing-kits-market-2021-industry-scope-with-outlook-business-strategies-major-key-players-and-forecast-2027/ Global Industrial Water Testing Kits Market instead, general economic developments and the outlook for 2021-2027 are indeed the accents of MarketQuest.biz research. Throughout the year 2021-2027, Industrial Water Test Kit is expected to generate profits (2020 is used as the starting point and 2027 as the projection period). Plus, that same report includes the full […]]]>

Global Industrial Water Testing Kits Market instead, general economic developments and the outlook for 2021-2027 are indeed the accents of MarketQuest.biz research. Throughout the year 2021-2027, Industrial Water Test Kit is expected to generate profits (2020 is used as the starting point and 2027 as the projection period). Plus, that same report includes the full projection of something like the CAGR (compound annual growth rate).

Based on the methodology of certain characteristics, at least a period of technological advancement has been carried out. While also incorporating secondary data sources, these certain strategies allow commentators to communicate their findings in a consistent manner.

DOWNLOAD A FREE SAMPLE REPORT: https://www.marketquest.biz/sample-request/42320

The Major Players Covered In The Global Market Report:

  • La Motte
  • Manufacturing Parker Hannifin
  • Taylor Technologies
  • E-WaterTest
  • KAR Laboratories
  • Micro Essential Laboratory
  • Transchem Agritech
  • Plasti Surge Industries
  • Flinn Scientist
  • Galgo
  • Camlab

The types segmented in the report are:

  • Ammonium
  • Nitrate
  • Nitrite
  • Calcium
  • Magnesium
  • Phosphate
  • Alkalinity
  • Potassium
  • PH
  • Others

The applications in the report are:

  • Industrial wastewater
  • Industrial manufacturing devices
  • Others

Entities considered to be reliable, including business intelligence of companies’ professional networks, regulatory requirements and general public announcements. The economic engineering standards for the Transnational Brand Identity Industrial Water Test Kit have also been included.

The research is based on important regions of the industry, including

  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy and rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
  • South America (Brazil, Argentina, Colombia and the rest of South America)
  • Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, South Africa and Rest of Middle East and Africa)

ACCESS TO THE FULL REPORT: https://www.marketquest.biz/report/42320/global-industrial-water-test-kit-market-2021-by-manufacturers-regions-type-and-application-forecast-to-2026

Significant differences between industrial water test kit and industrial water test kit appear to be significant. Although it was necessary to identify mainly specific major financial institutions to better understand how to establish yourself as little more than a business. Research by institutional investors on reputation, technical progress, economic capacities and external opportunities and threats

Customization of the report:

This report can be customized to meet customer requirements. Please connect with our sales team (sales@marketquest.biz), who will make sure you get a report that matches your needs. You can also contact our leaders at + 1-201-465-4211 to share your research needs.

Contact us
Brand Pierre
Head of Business Development
Telephone: + 1-201-465-4211
E-mail: sales@marketquest.biz


Source link

]]>
https://imphos.org/global-industrial-water-testing-kits-market-2021-industry-scope-with-outlook-business-strategies-major-key-players-and-forecast-2027/feed/ 0
Sphingosine 1-Phosphate Receptor (S1PR) Modulator Market Size, Global Opportunities, Driving Forces, Future Potential 2025 https://imphos.org/sphingosine-1-phosphate-receptor-s1pr-modulator-market-size-global-opportunities-driving-forces-future-potential-2025/ https://imphos.org/sphingosine-1-phosphate-receptor-s1pr-modulator-market-size-global-opportunities-driving-forces-future-potential-2025/#respond Mon, 20 Sep 2021 05:30:56 +0000 https://imphos.org/sphingosine-1-phosphate-receptor-s1pr-modulator-market-size-global-opportunities-driving-forces-future-potential-2025/ The research report of Sphingosine 1-Phosphate Receptor Modulator (S1PR) Market highlights the key growth drivers and opportunities influencing the industry growth matrix over the period 2020-2025. It also covers the challenges that will impact the business sphere profitability graph during the analysis period and includes measures to combat their impact. Taking the analysis further, the […]]]>

The research report of Sphingosine 1-Phosphate Receptor Modulator (S1PR) Market highlights the key growth drivers and opportunities influencing the industry growth matrix over the period 2020-2025. It also covers the challenges that will impact the business sphere profitability graph during the analysis period and includes measures to combat their impact.

Taking the analysis further, the research paper analyzes the market at the micro and macro level fragmenting it based on scope of application, product spectrum, and regional scope. Past records and current data are compared to provide industry players with an in-depth understanding of how the industry works that will enable them to make the right decisions that maximize profits.

Key Inclusions of the Sphingosine 1-Phosphate Receptor (S1PR) Modulator Market report:

  • Details regarding sales volume, overall market revenue and market size
  • Growth rate projections over the period of analysis
  • Crucial insight into industry trends and growth opportunities
  • Advantages and disadvantages of using indirect and direct sales channels
  • List of the main resellers, traders and distributors in the field of business

Request a copy of this report @ https://www.nwdiamondnotes.com/request-sample/14976

Sphingosine 1-Phosphate Receptor (S1PR) Modulator Market Segments Covered In The Report:

Product line:

  • S1P1 subtype and S1P5 subtype
  • Price models for each type of product
  • Projected market share for each type of product in terms of revenue and sales

Application spectrum:

  • RMS treatment for clinical symptoms of RMS in adults and relive
  • Revenue generated and sales volume for each type of application
  • Projections of the growth rate of each type of demand during the study period

Company Profiles:

  • Pharmaceutical company Novartis
  • Celgene
  • Bristol-MyersSquibb Company
  • JNJ (Janssen)
  • Biogen and Merck

  • Detailed information on the product and service offerings of listed companies.
  • Statistical data associated with the production capacity, profit margins, product prices, sales, revenues and market share of each player
  • Sales channels used by large companies
  • SWOT analysis of leading companies
  • Review of market rate to market, market concentration rate, marketing strategies and other business aspects

Regional fragmentation:

  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy and rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
  • South America (Brazil, Argentina, Colombia and the rest of South America)
  • Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, South Africa and Rest of Middle East and Africa)
  • Market analysis at national and regional level.
  • Growth rate and revenue projections for each region over the forecast period
  • Revenue generated, sales accumulated and market share captured by each region

The report answers questions such as:

What is the current size of the global sphingosine 1-phosphate receptor (S1PR) modulator market?

How much will this market be worth from 2020 to 2025?

Which country is expected to hold the highest market share in the global Sphingosine 1-Phosphate Receptor (S1PR) market?

What are the key drivers and restraints in the global sphingosine 1-phosphate receptor modulator (S1PR) market?

Who are the main players and what are their activities, revenues, recent developments and prospects?

Request customization on this report @ https://www.nwdiamondnotes.com/request-for-customization/14976


Source link

]]>
https://imphos.org/sphingosine-1-phosphate-receptor-s1pr-modulator-market-size-global-opportunities-driving-forces-future-potential-2025/feed/ 0
Phosphine on Venus, an indicator of life: scientists after heated debate https://imphos.org/phosphine-on-venus-an-indicator-of-life-scientists-after-heated-debate/ https://imphos.org/phosphine-on-venus-an-indicator-of-life-scientists-after-heated-debate/#respond Sun, 19 Sep 2021 11:30:38 +0000 https://imphos.org/phosphine-on-venus-an-indicator-of-life-scientists-after-heated-debate/ In September 2020, an international team of scientists reported the discovery of phosphine in the clouds of Venus using data from the Atacama Large Millimeter / submillimeter Array (ALMA) observatory. Phosphine is a colorless, flammable gas that naturally only exists in living processes on earth. The discovery meant that either scientists did not know of […]]]>

In September 2020, an international team of scientists reported the discovery of phosphine in the clouds of Venus using data from the Atacama Large Millimeter / submillimeter Array (ALMA) observatory. Phosphine is a colorless, flammable gas that naturally only exists in living processes on earth. The discovery meant that either scientists did not know of an unknown non-living origin for the chemical, or it could be a clue that Venus has microbes that could produce phosphine. Since Venus is full of volcanic activity and lava flow raising its surface temperature to 464 degrees Celsius, the research has drawn criticism and other scientists have suggested that there may be an error in the data collected. by the observatory. In July 2021, an independent study falsified their findings on phosphine on Venus. On that day, the authors of the original study clarified in an addendum to their research that they themselves had tested their procedure and data and that it was very clear that the data showed the existence of phosphine. .

Now, in a new study, the authors of the original study have addressed yet another claim questioning their findings and after performing analysis based on the counterclaim that the results may have been heavily contaminated with sulfur dioxide. . Scientists say in the new study that the sulfur dioxide contamination was low enough and that the phosphine detection was not a mistake. To questions about the error in the data, the scientists used another simultaneous observation of Venus from another observatory – the James Clerk Maxwell Telescope (JCMT).

“We are convinced that the discovery of phosphine is real. But we don’t know what does it, ”Dave Clements, one of the study’s authors, told The Daily Star. The study was submitted on August 18 and has yet to be published in Earth and Planetary Astrophysics.

According to Clements, to better understand how phosphine is produced naturally on earth, scientists plan to study the lifestyle of gentoo penguins, which are common to the Falkland Islands, an archipelago 480 kilometers northeast of the southern tip. from South America.

Phosphine on earth can also be produced by certain anaerobic bacteria. In non-living processes, phosphine is not produced because of the oxygenated environment of the earth. Rather than existing in a reduced form (phosphine), phosphorus on earth exists in its most oxidized form (phosphate). While the origin of phosphine is still debated, the only living processes – bacteria, penguins – are still known to produce phosphine.

Read all the latest news, breaking news and coronavirus news here


Source link

]]>
https://imphos.org/phosphine-on-venus-an-indicator-of-life-scientists-after-heated-debate/feed/ 0